Figure 1
Study design. BL, baseline; CVD, cardiovascular disease; FU, follow-up; HTN, hypertension. Prevalent hypertension: SBP ≥140 mmHg and/or DBP ≥90 mmHg or anti-HTN drug intake. Prevalent CVD: myocardial infarction, coronary heart disease, congestive heart failure, atrial fibrillation, and stroke.

Study design. BL, baseline; CVD, cardiovascular disease; FU, follow-up; HTN, hypertension. Prevalent hypertension: SBP ≥140 mmHg and/or DBP ≥90 mmHg or anti-HTN drug intake. Prevalent CVD: myocardial infarction, coronary heart disease, congestive heart failure, atrial fibrillation, and stroke.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close